International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
复制标题
DOI：
10.1093/cid/ciq257
复制
发表时间：
2011-03-01
影响因子：
11.8
通讯作者：
Soper, David E.
中科院分区：
文献类型：
--
作者：
Gupta, Kalpana;Hooton, Thomas M.;Soper, David E.
美国传染病学会（IDSA）与欧洲微生物学和传染病学会（ESCMID）合作召集了一个国际专家小组，以更新IDSA 1999年的《单纯性尿路感染指南》。共同赞助组织包括美国妇产科医师大会、美国泌尿科协会、加拿大医学微生物学和传染病协会以及学术急诊医学协会。这项工作的重点是治疗患有急性无并发症膀胱炎和肾盂肾炎的女性，在这些指南中，诊断仅限于绝经前非妊娠女性，没有已知的泌尿系统异常或合并症。体外耐药流行率和抗菌治疗的生态不良影响（附带损害）问题被认为是做出最佳治疗选择的重要因素，因此反映在推荐的排名中。
A Panel of International Experts was convened by the Infectious Diseases Society of America (IDSA) in collaboration with the European Society for Microbiology and Infectious Diseases (ESCMID) to update the 1999 Uncomplicated Urinary Tract Infection Guidelines by the IDSA. Co-sponsoring organizations include the American Congress of Obstetricians and Gynecologists, American Urological Association, Association of Medical Microbiology and Infectious Diseases-Canada, and the Society for Academic Emergency Medicine. The focus of this work is treatment of women with acute uncomplicated cystitis and pyelonephritis, diagnoses limited in these guidelines to premenopausal, non-pregnant women with no known urological abnormalities or co-morbidities. The issues of in vitro resistance prevalence and the ecological adverse effects of antimicrobial therapy (collateral damage) were considered as important factors in making optimal treatment choices and thus are reflected in the rankings of recommendations.